Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kristinsson

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Diabetes, Obesity & Metabolism|July 12, 2013
Application of the International Diabetes Federation and American Diabetes Association criteria in the assessment of metabolic control after bariatric surgeryA D Miras, H Risstad, N Baqai, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2019
Bariatric surgery at Oslo University Hospital 2004–14Odd Bjørn Salte, Torgeir Thorson Søvik, Hilde Risstad, et al.
Circulation|November 1, 1993
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality StudyH D White, G I Barbash, M Modan, et al.
Journal of Cardiovascular Pharmacology|July 1, 1996
Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patientsL Hansson, T Forslund, C Höglund, et al.
Obesity Surgery|May 9, 2019
Bone Turnover Markers After Standard and Distal Roux-en-Y Gastric Bypass: Results from a Randomized Controlled TrialMarius Svanevik, Hilde Risstad, Dag Hofsø, et al.
Obesity Surgery|September 3, 2017
Patient-Reported Outcome Measures 2 Years After Standard and Distal Gastric Bypass-a Double-Blind Randomized Controlled TrialMarius Svanevik, Hilde Risstad, Tor-Ivar Karlsen, et al.
JAMA Network Open|June 3, 2024
Ten-Year Outcomes Following Roux-en-Y Gastric Bypass vs Duodenal Switch for High Body Mass Index: A Randomized Clinical TrialOdd Bjørn Kjeldaas Salte, Torsten Olbers, Hilde Risstad, et al.
Archives of Internal Medicine|October 10, 1994
Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality TrialG I Barbash, H D White, M Modan, et al.
Circulation|January 1, 1993
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality TrialG I Barbash, H D White, M Modan, et al.
European Heart Journal|March 1, 1995
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality TrialG I Barbash, H D White, M Modan, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Diabetes, Obesity & Metabolism|July 12, 2013
Application of the International Diabetes Federation and American Diabetes Association criteria in the assessment of metabolic control after bariatric surgeryA D Miras, H Risstad, N Baqai, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2019
Bariatric surgery at Oslo University Hospital 2004–14Odd Bjørn Salte, Torgeir Thorson Søvik, Hilde Risstad, et al.
Circulation|November 1, 1993
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality StudyH D White, G I Barbash, M Modan, et al.
Journal of Cardiovascular Pharmacology|July 1, 1996
Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patientsL Hansson, T Forslund, C Höglund, et al.
Obesity Surgery|May 9, 2019
Bone Turnover Markers After Standard and Distal Roux-en-Y Gastric Bypass: Results from a Randomized Controlled TrialMarius Svanevik, Hilde Risstad, Dag Hofsø, et al.
Obesity Surgery|September 3, 2017
Patient-Reported Outcome Measures 2 Years After Standard and Distal Gastric Bypass-a Double-Blind Randomized Controlled TrialMarius Svanevik, Hilde Risstad, Tor-Ivar Karlsen, et al.
JAMA Network Open|June 3, 2024
Ten-Year Outcomes Following Roux-en-Y Gastric Bypass vs Duodenal Switch for High Body Mass Index: A Randomized Clinical TrialOdd Bjørn Kjeldaas Salte, Torsten Olbers, Hilde Risstad, et al.
Archives of Internal Medicine|October 10, 1994
Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality TrialG I Barbash, H D White, M Modan, et al.
Circulation|January 1, 1993
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality TrialG I Barbash, H D White, M Modan, et al.
European Heart Journal|March 1, 1995
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality TrialG I Barbash, H D White, M Modan, et al.
Pageof 5